| Phenotype name | HPO term suggestion | Frequency / penetrance | Age of onset | Severity | Key clinical characteristics |
|---|---|---|---|---|---|
| Sinus bradycardia | HP:0001662 Bradycardia | Very common/core phenotype in HCN4-related disease; human HCN4 literature summarized 22 variants linked to SND, with 13 showing clear genotype-phenotype association; penetrance is variable and often incomplete in heterozygous families (pqac-00000001, pqac-00000018) | Variable; can present in embryonic life in models, childhood/young adulthood in familial cases, or adulthood; symptomatic case described at age 49 years (pqac-00000017, pqac-00000019) | Mild to severe | Resting sinus rates can be markedly reduced; example patient had 37 bpm, and animal models show severe intrinsic SAN slowing (pqac-00000007, pqac-00000005) |
| Chronotropic incompetence | HP:0005209 Chronotropic incompetence | Common in SAN dysfunction due to HCN4 dysregulation, but exact human penetrance not well quantified (pqac-00000005, pqac-00000008) | Usually recognized when exercise or autonomic challenge fails to raise heart rate appropriately; adult case documented (pqac-00000007, pqac-00000019) | Moderate to severe | Failure to achieve expected heart-rate increase during exercise or stress; reflects impaired autonomic/SAN responsiveness (pqac-00000007, pqac-00000005) |
| Sinus pauses | HP:0030247 Sinus pause | Common in experimental models and reported in human cases; exact penetrance unknown (pqac-00000008, pqac-00000027) | Variable; can occur in adult symptomatic disease and in inducible/conditional mouse models (pqac-00000007, pqac-00000027) | Moderate to severe | Pauses may exceed 2-3 seconds; example Holter showed pauses up to 3 seconds; recurrent pauses are a hallmark of reduced HCN4 function (pqac-00000007, pqac-00000026) |
| Sinus arrest | HP:0011706 Sinus arrest | Reported as part of the SND spectrum; frequency not well quantified for HCN4 specifically (pqac-00000000, pqac-00000030) | Variable | Severe | Represents failure of impulse generation by the SAN; contributes to dizziness, presyncope/syncope, and pacemaker requirement (pqac-00000000, pqac-00000030) |
| Sinoatrial exit block / impaired impulse transmission | HP:0011710 Sinoatrial block | Recognized component of SND/SSS spectrum; specific HCN4 penetrance not quantified (pqac-00000001, pqac-00000031) | Variable | Mild to severe | SAN automaticity may be preserved but conduction from SAN to atrium is impaired; part of intrinsic SAN inadequacy definition (pqac-00000001, pqac-00000031) |
| Sinus dysrhythmia / irregular sinus rhythm | HP:0011708 Cardiac dysrhythmia | Prominent in HCN4 mouse models and likely relevant to human disease; exact human frequency unknown (pqac-00000005, pqac-00000009) | Variable | Mild to severe | Large beat-to-beat variability and unstable pacemaker output; severe sinus dysrhythmia described in HCN4FEA mice (pqac-00000005, pqac-00000029) |
| Atrial fibrillation | HP:0005110 Atrial fibrillation | Increased susceptibility reported with HCN4-related SND, but not universal; variable expressivity (pqac-00000006, pqac-00000030) | Usually later than isolated bradycardia; variable | Moderate to severe | May coexist with bradycardia/tachycardia syndrome; can contribute to embolic risk and cardiomyopathy (pqac-00000006, pqac-00000030) |
| Paroxysmal supraventricular tachyarrhythmia / tachy-brady syndrome | HP:0005117 Supraventricular tachycardia | Part of the broader SSS phenotype spectrum; exact penetrance not established (pqac-00000000, pqac-00000031) | Variable | Moderate | Alternation of slow and fast atrial rhythms is characteristic of sick sinus syndrome and may complicate management (pqac-00000000, pqac-00000031) |
| Dizziness / presyncope | HP:0002321 Vertigo or HP:0001288 Lightheadedness | Symptomatic manifestation rather than core electrophysiologic trait; frequency depends on bradycardia severity (pqac-00000007, pqac-00000019) | Typically when clinically manifest disease develops | Mild to moderate | Example patient presented with dizziness and nausea accompanying marked sinus bradycardia (pqac-00000007, pqac-00000019) |
| Pacemaker requirement | HP:0005304 Cardiac pacemaker implantation | Common in clinically significant symptomatic SND; exact percentage for HCN4 families unavailable (pqac-00000022, pqac-00000019) | Often adulthood, when symptomatic bradycardia/pauses become clinically significant | Severe disease indicator | Permanent pacing is the definitive treatment for chronic symptomatic SND and reflects advanced functional impact (pqac-00000022, pqac-00000019) |
| Left ventricular noncompaction cardiomyopathy | HP:0012810 Left ventricular noncompaction | Reported in a subset of HCN4 mutation carriers; variable expressivity and not present in all families (pqac-00000006, pqac-00000018) | Variable; may be recognized with cardiac imaging after arrhythmia workup | Moderate to severe | Excessive ventricular trabeculation/hypertrabeculation; may be accompanied by heart failure, arrhythmias, and thromboembolic risk (pqac-00000006, pqac-00000011) |
| Heart failure / cardiomyopathy complications | HP:0001635 Congestive heart failure | Secondary/less common manifestation, particularly when structural cardiomyopathy co-occurs (pqac-00000006, pqac-00000011) | Usually later/complication stage | Severe | Seen mainly in mutation carriers with associated noncompaction or tachycardia-induced cardiomyopathy rather than isolated sinus node dysfunction (pqac-00000006, pqac-00000011) |


*Table: This table summarizes the principal clinical manifestations reported for HCN4-related sick sinus syndrome 2, including suggested HPO terms and practical notes on onset, severity, and penetrance. It is useful for phenotype curation and disease knowledge base population.*